first glp 1 approved for weight loss GLP-1 Options Medicare launches first GLP-1 weight-loss

Ongoing monitoring by a clinician ensures safety, tracks progress, and tailors treatment over time

Clinical Judgment : Monitoring decisions should be individualized based on the balance of fracture risk factors, expected weight loss, treatment duration, and patient preferences

Here are the questions every fertility clinic should be asking: Are we tracking response times, abandoned calls, and repeat callers within 24 hours

The Phase 2 trial published in the New England Journal of Medicine in 2023 reported up to 24% average weight loss at 48 weeks at the highest dose the largest number ever recorded for an obesity drug

This may be due to the effects of female hormones: estrogens increase cholesterol secretion into bile, and progesterone decreases gallbladder motility